The untreated spheroids remained intact, whereas the combinatorial treatment of sFPR4 and chemotherapeutic drugs showed disruption of spheroids post-treatment (Fig. 1), indicating sFRP4’s capacity to segregate the tumor spheres and allow chemotherapeutic drugs to inhibit tumor proliferation. This evidence concerns the gene SFRP4 and neoplasm.